Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo

The Prostate
Sharmila ShankarRakesh K Srivastava

Abstract

Tumor necrosis factor related apoptosis-inducing ligand/Apo2 ligand (TRAIL/Apo-2L) is a novel anticancer agent, capable of inducing apoptosis preferentially in tumor and transformed cells. TRAIL-R1/death receptor (DR)4 and TRAIL-R2/DR5 are members of the tumor necrosis factor (TNF) receptor family, and can be activated by the TRAIL. We examined the clinical potential of chemotherapeutic drugs and TRAIL for the treatment of prostate cancer. Prostate and bladder cancer cells were exposed to chemotherapeutic drugs (paclitaxel, vincristine, vinblastine, etoposide, doxorubicin, and camptothecin) and TRAIL. Cell viability was measured by sodium 3'[1-(phenylaminocarbonyl)-3,4-tetrazolium]-bis (4-methoxy-6-nitro) assay; expressions of death receptors and Bcl-2 family members were measured by Western blotting, ELISA and ribonuclease protection assay. PC-3 tumor cells xenografted athymic nude mice were exposed to chemotherapeutic drugs and TRAIL, either alone or in combination, to measure tumor growth and survival of mice. Apoptosis was measured by annexin V-FITC/propidium iodide staining, and terminal deoxynucleotidyltransferase-mediated nick end labeling assay. Caspase-3 activity was measured by the Western blotting and immunohistochem...Continue Reading

References

Aug 17, 1989·The New England Journal of Medicine·E D CrawfordP J Goodman
Apr 4, 1997·Science·G PanV M Dixit
Aug 1, 1997·Trends in Biochemical Sciences·D W Nicholson, N A Thornberry
Oct 7, 1997·The Journal of Experimental Medicine·M A Degli-EspostiC A Smith
Dec 31, 1997·FEBS Letters·P SchneiderJ Tschopp
Jan 1, 1997·British Medical Bulletin·N A Thornberry
Feb 21, 1998·Current Biology : CB·S A MarstersA Ashkenazi
Dec 9, 1997·Cell·G S Salvesen, V M Dixit
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·J M JürgensmeierJ C Reed
Jun 11, 1998·The Journal of Biological Chemistry·J G EmeryP R Young
Feb 17, 1999·Genes & Development·Q L Deveraux, J C Reed
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·R K SrivastavaD L Longo
Apr 14, 1999·CA: a Cancer Journal for Clinicians·S H LandisP A Wingo
Aug 13, 1999·Genes & Development·A GrossS J Korsmeyer
Jan 14, 2000·Journal of Clinical Immunology·Q L DeverauxJ C Reed
Dec 15, 2000·Cell·K H Vousden
Feb 15, 2001·Molecular Cell Biology Research Communications : MCBRC·R K Srivastava
May 10, 2001·Current Opinion in Cell Biology·K M RyanK H Vousden
Dec 12, 2001·Seminars in Oncology·J Folkman
Apr 10, 2002·The Journal of Biological Chemistry·Youngsoo KimJohn C Reed
Jun 1, 2002·The Journal of Biological Chemistry·Yuki HamanoRaghu Kalluri
Jul 12, 2002·Cancer Chemotherapy and Pharmacology·A MunshiR E Meyn
Aug 3, 2002·Nature Reviews. Cancer·Karen H Vousden, Xin Lu
Nov 15, 2002·Cancer Biology & Therapy·Marc L HyerJames S Norris
Mar 26, 2003·Cell Death and Differentiation·H N LeBlanc, A Ashkenazi

❮ Previous
Next ❯

Citations

May 24, 2007·Apoptosis : an International Journal on Programmed Cell Death·Claudia Alexandra DumitruErich Gulbins
Feb 6, 2009·Apoptosis : an International Journal on Programmed Cell Death·Thomas Newsom-DavisHenning Walczak
Dec 29, 2009·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Qin ShenJiawen Li
Aug 18, 2010·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Jiawen LiJingjing Lu
May 21, 2013·Cancer Letters·Min ZhaoRakesh K Srivastava
Jun 22, 2013·Nano Letters·Naama E Toledano FurmanMarcelle Machluf
Oct 22, 2005·Nature Reviews. Cancer·Stephen W Fesik
Sep 25, 2008·Nature Reviews. Cancer·Ricky W JohnstoneMark J Smyth
May 18, 2005·Oncogene·Thiyam Ramsing SinghRakesh K Srivastava
Apr 15, 2010·Thorax·Michael R Loebinger, Sam M Janes
Jun 17, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mary M McCarthyHarriet M Kluger
Apr 22, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Suizhao WangDina Lev
Mar 25, 2006·Future Oncology·Zodwa DlaminiThokozile Ledwaba
Sep 5, 2009·Apoptosis : an International Journal on Programmed Cell Death·Sonia ArouiAbderraouf Kenani
May 26, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Liangran GuoXinguo Jiang
Oct 7, 2009·Gynecologic Oncology·Katherine Marie MoxleyDoris Mangiaracina Benbrook
Jan 2, 2009·Cancer Treatment Reviews·Devalingam MahalingamAfshin Samali
Nov 22, 2005·The Journal of Investigative Dermatology·Bahtier M KurbanovJürgen Eberle
Oct 29, 2008·Hematology/oncology Clinics of North America·Luca PaoluzziOwen A O'Connor
Dec 13, 2006·The Journal of Urology·Ahter Dilsad SanliogluSalih Sanlioglu
May 10, 2007·The British Journal of Dermatology·J EberleE Stockfleth
Aug 21, 2008·International Journal of Cancer. Journal International Du Cancer·Daniel Floryk, Timothy C Thompson
Aug 30, 2008·Molecular Carcinogenesis·Liqing XiaoMarcelo G Kazanietz
May 4, 2013·British Journal of Pharmacology·O MicheauF Dufour

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Molecular Cell Biology Research Communications : MCBRC
Rakesh K Srivastava
The Journal of Clinical Investigation
Avi AshkenaziR H Schwall
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
Sharmila Shankar, Rakesh K Srivastava
© 2021 Meta ULC. All rights reserved